TY - JOUR
T1 - LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophy
AU - Nichterwitz, Susanne
AU - Nijssen, Jik
AU - Storvall, Helena
AU - Schweingruber, Christoph
AU - Comley, Laura Helen
AU - Allodi, Ilary
AU - Lee, Mirjam van der
AU - Deng, Qiaolin
AU - Sandberg, Rickard
AU - Hedlund, Eva
N1 - Funding: This work was supported by grants from the Swedish Research Council (2016-02112) to E.H., European Union Joint Programme for Neurodegenerative Disease (JPND) (529-2014-7500) to E.H. and R.S., and the Karolinska Institutet to E.H. C.S. was supported by a postdoctoral fellowship from the Swiss National Science Foundation.
PY - 2020/8/20
Y1 - 2020/8/20
N2 - Somatic motor neurons are selectively vulnerable in spinal muscular atrophy (SMA), which is caused by a deficiency of the ubiquitously expressed survival of motor neuron protein. However, some motor neuron groups, including oculomotor and trochlear (ocular), which innervate eye muscles, are for unknown reasons spared. To reveal mechanisms of vulnerability and resistance in SMA, we investigate the transcriptional dynamics in discrete neuronal populations using laser capture microdissection coupled with RNA sequencing (LCM-seq). Using gene correlation network analysis, we reveal a TRP53-mediated stress response that is intrinsic to all somatic motor neurons independent of their vulnerability, but absent in relatively resistant red nucleus and visceral motor neurons. However, the temporal and spatial expression analysis across neuron types shows that the majority of SMA-induced modulations are cell type-specific. Using Gene Ontology and protein network analyses, we show that ocular motor neurons present unique disease-adaptation mechanisms that could explain their resilience. Specifically, ocular motor neurons up-regulate (1) Syt1, Syt5, and Cplx2, which modulate neurotransmitter release; (2) the neuronal survival factors Gdf15, Chl1, and Lif; (3) Aldh4, that protects cells from oxidative stress; and (4) the caspase inhibitor Pak4. Finally, we show that GDF15 can rescue vulnerable human spinal motor neurons from degeneration. This confirms that adaptation mechanisms identified in resilient neurons can be used to reduce susceptibility of vulnerable neurons. In conclusion, this in-depth longitudinal transcriptomics analysis in SMA reveals novel cell type-specific changes that, alone and combined, present compelling targets, including Gdf15, for future gene therapy studies aimed toward preserving vulnerable motor neurons.
AB - Somatic motor neurons are selectively vulnerable in spinal muscular atrophy (SMA), which is caused by a deficiency of the ubiquitously expressed survival of motor neuron protein. However, some motor neuron groups, including oculomotor and trochlear (ocular), which innervate eye muscles, are for unknown reasons spared. To reveal mechanisms of vulnerability and resistance in SMA, we investigate the transcriptional dynamics in discrete neuronal populations using laser capture microdissection coupled with RNA sequencing (LCM-seq). Using gene correlation network analysis, we reveal a TRP53-mediated stress response that is intrinsic to all somatic motor neurons independent of their vulnerability, but absent in relatively resistant red nucleus and visceral motor neurons. However, the temporal and spatial expression analysis across neuron types shows that the majority of SMA-induced modulations are cell type-specific. Using Gene Ontology and protein network analyses, we show that ocular motor neurons present unique disease-adaptation mechanisms that could explain their resilience. Specifically, ocular motor neurons up-regulate (1) Syt1, Syt5, and Cplx2, which modulate neurotransmitter release; (2) the neuronal survival factors Gdf15, Chl1, and Lif; (3) Aldh4, that protects cells from oxidative stress; and (4) the caspase inhibitor Pak4. Finally, we show that GDF15 can rescue vulnerable human spinal motor neurons from degeneration. This confirms that adaptation mechanisms identified in resilient neurons can be used to reduce susceptibility of vulnerable neurons. In conclusion, this in-depth longitudinal transcriptomics analysis in SMA reveals novel cell type-specific changes that, alone and combined, present compelling targets, including Gdf15, for future gene therapy studies aimed toward preserving vulnerable motor neurons.
KW - Adaptation, physiological/genetics
KW - Animals
KW - Cells, cultured
KW - Disease models, animal
KW - Eye/innervation
KW - Genetic predisposition to disease/genetics
KW - Growth differentiation factor 15/genetics
KW - Laser capture microdissection
KW - Mice
KW - Mice, knockout
KW - Motor cortex/pathology
KW - Motor neurons/metabolism
KW - Muscular atrophy, spinal/genetics
KW - Neuroprotection/genetics
KW - Sequence analysis, RNA
KW - Survival of motor neuron 1 protein/genetics
KW - Survival of motor neuron 2 protein/genetics
KW - Transcriptional activation/genetics
KW - Tumor suppressor protein p53/genetics
U2 - 10.1101/gr.265017.120
DO - 10.1101/gr.265017.120
M3 - Article
C2 - 32820007
SN - 1088-9051
VL - 30
SP - 1083
EP - 1096
JO - Genome Research
JF - Genome Research
IS - 8
ER -